Antibodies

Items 121-130 of 164

per page
Set Descending Direction
  1. anti-DR3 (human), mAb (ANC2D12) (preservative free)
    ANC-250-820.
    ANC-250-820100 µg
    CHF 306.00
  2. anti-Fas (human), mAb (APO-1-1) (preservative free)
    AG-20B-0079PF
    AG-20B-0079PF-C100100 µg
    CHF 240.00
    AG-20B-0079PF-C500500 µg
    CHF 750.00
  3. anti-Fas (human), mAb (APO-1-3) (preservative free)
    AG-20B-0062PF
    AG-20B-0062PF-C05050 µg
    CHF 150.00
    AG-20B-0062PF-C100100 µg
    CHF 240.00
    AG-20B-0062PF-C500500 µg
    CHF 750.00
    anti-Fas (human), mAb (APO-1-3) (preservative free)
  4. anti-GITR (human), mAb (AIT 158D)
    AG-20A-0017
    AG-20A-0017-C05050 µg
    CHF 270.00
    AG-20A-0017-C100100 µg
    CHF 350.00
    FACS: Con A-activated human T lymphocytes stained significantly using anti-GITR (human), mAb (AIT 158D) (Prod. No. AG-20A-0017).
  5. anti-GITR (human), pAb
    AG-25A-0017
    AG-25A-0017-C100100 µg
    CHF 390.00
    FACS: Con A activated human T lymphocytes were stained significantly using anti-GITR (human), pAb (Prod. No. AG-25A-0017).
  6. anti-GITR (mouse), mAb (MGIT 02)
    AG-20A-0007
    AG-20A-0007-C100100 µg
    CHF 190.00
    FACS: GITR-transfected HEK 293 cells stained significantly using anti-GITR (mouse), mAb (MGIT 02) (Prod. No. AG-20A-0007).
  7. anti-GITRL (human), pAb
    AG-25A-0023
    AG-25A-0023-C100100 µg
    CHF 390.00
    Immunohistochemical staining of GITRL using anti-GITRL (human), pAb (Prod. No. AG-25A-0023) in human uterus tissue (5µg/ml). This antibody has been tested in immunohistochemistry, analyzed by an anatomic pathologist and validated for use in IH
  8. anti-IGFLR1 (human), pAb (IN101)
    AG-25B-0026
    AG-25B-0026-C100100 µg
    CHF 190.00
  9. anti-LTβR (human), mAb (ANCLTR2/9E2)
    ANC-267-020.
    ANC-267-020100 µg
    CHF 306.00
  10. anti-LTβR (human), mAb (ANCLTR2/9E2) (Biotin)
    ANC-267-030.
    ANC-267-030100 µg
    CHF 423.00

Items 121-130 of 164

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.